Polo-like kinase 1 is a potential therapeutic target in human melanoma.
Jalili A, Moser A, Pashenkov M, Wagner C, Pathria G, Borgdorff V, Gschaider M, Stingl G, Ramaswamy S, Wagner SN.
Jalili A, et al. Among authors: moser a.
J Invest Dermatol. 2011 Sep;131(9):1886-95. doi: 10.1038/jid.2011.136. Epub 2011 Jun 9.
J Invest Dermatol. 2011.
PMID: 21654832
Free article.